Ultrastructural changes of platelet aggregates and fibrin networks in a patient with renal clear cell adenocarcinoma: A scanning electron microscopy study

Microscopy Research and Technique

Volumn 72, Issue 9, 2009, Pages 679-683

  Pretorius, Etheresia ^a,b   Bornman, Maria S ^a   Reif, Simon ^a   Oberholzer, Hester M ^a   Franz, Robert C ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Apoptosis; Paraneoplastic syndrome; Platelet aggregates; Renal cancer

Indexed keywords

AGGREGATES; CHEMOTHERAPY; PLASMA (HUMAN); PLATELETS; SCANNING ELECTRON MICROSCOPY;

BONE METASTASIS; FIBRIN NETWORK; LIVER METASTASIS; PARANEOPLASTIC SYNDROME; PLATELET AGGREGATE; PULMONARY METASTASIS; RENAL CANCERS; RENAL CARCINOMA; ULTRASTRUCTURAL CHANGES; WEIGHT LOSS;

CELL DEATH;

ANTINEOPLASTIC AGENT; FIBRIN; GLUTARALDEHYDE; THROMBIN;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORPHOLOGY; CASE REPORT; CELL ULTRASTRUCTURE; CLEAR CELL CARCINOMA; CYTOREDUCTIVE SURGERY; FIBRIN CLOT; HEMATURIA; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE RICH PLASMA; WEIGHT REDUCTION;

EID: 69249106041     PISSN: 1059910X     EISSN: 10970029     Source Type: Journal    
DOI: 10.1002/jemt.20718     Document Type: Article

References (30)

1. Besalah K, Leray E, Fergelot P, Rioux-Leclercq N, Tostain J, Guillé F, Patard J-J. 2006. Prognostic value of thrombocytosis in renal cell carcinoma. J Urol 175:859-863. (Pubitemid 43199997)
2. Blay J-Y, Negrier S, Combaret V, Attali S, Goillot E, Merrouche Y, Mercatello A, Ravault A, Tourani JM, Moskovtchenko JF, Philip T, Favrot M. 1992. Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res 52:3317.
3. Blay J-Y, Favrot M, Rossi JF, Wijdenes J. 1993. Role of interleukin-6 in paraneoplastic thrombocytosis [letter]. Blood 82:2261-2262. (Pubitemid 23294019)
4. Bornman MS, Pretorius E, Marx J, Smit E, van der Merwe CF. 2007. Ultrastructural effects of DDT, DDD and DDE on neural cells of the chicken embryo model. Environ Toxicol 22:328-336. (Pubitemid 46842175)
5. Cohen HT, McGovern FJ. 2005. Renal cell carcinoma. N Engl J Med 353:2477.
6. Giannakos G, Papanicolaou X, Trafalis D, Michaelidis I, Margaritis G, Christofilakis C. 2005. Stauffer's syndrome variant associated with renal cell carcinoma. Int J Urol 12:757-759. (Pubitemid 41743360)
7. Gottlieb RA, Wyllie AH, Ker JFR, Currie AR. 1980. Cell death: The significance of apoptosis. Int Rev Cytol 68:251.
8. Groves E, Dart AE, Covarelli V, Caron E. 2008. Molecular mechanisms of phagocytic uptake in mammalian cells. Cell Mol Life Sci 65:1957-1976.
9. Hilgard P. 1973. The role of blood platelets in experimental metastasis. Brit J Haemat 28:429-435.
10. Hollen CW, Henthorn J, Koziol JA, Burstein SA. 1991. Elevated serum interleukin-6 levels in patients with reactive thrombocytosis. Br J Haematol 79:286.
11. Jameson JL, Johnson BE. 2008. Harrisons Principles of Internal Medicine, 17th ed. New York: McGraw Hill.622p.
12. Janik JE, Sznol M, Urba WJ, Figlin R, Bukowski RM.Fyfe G, Pierce WC, Belldegrun A, Sharfman WH, Smith JW. 1993. Erythropoietin production. A potential marker for interleukin-2/interferon-responsive tumors. Cancer 72:2656-2659.
13. Jemal A, Thomas A, Murray T, Thun M. 2002. Cancer statistics CA. Cancer J Clin 52:23-47.
14. Kalazhny Y, Ravid K. 2004. Role of apoptotic processes in platelet biogenesis. Acta Haematol 111:67. (Pubitemid 37499956)
15. Kim HI, Belldegrun AS, Freitas DG, Bui MHT, Han K-R, Dorey FJ, Figlin RA. 2003. Paraneoplastic signs and symptoms of renal cell carcinoma: Implications for prognosis. J Urol 170:1742-1746. (Pubitemid 37254919)
16. Kontak JA, Campbell SC. 2003. Prognostic factors in renal cell carcinoma. Urol Clin North Am 30:467.
17. Majno G, Joris I. 1995. Apoptosis, oncosis, and necrosis: An overview of cell death. Am J Pathol 146:3-15.
18. Mantur M, Kemona H, Pietruczuk M, Wasiluk A. 2002. Does renal carcinoma affect the expression of P-selectin on platelets? Neoplasma 49:243-245.
19. Mantur M, Kemona H, Kozlowski R, Kemona-Chetnik I. 2003. Effect of tumor stage and nephrectomy on CD62P expression and sP-selectin concentration in renal cancer. Neoplasma 50:262-265. (Pubitemid 37128058)
20. Matowicka-Karna J, Mantur M, Darewicz B, Kemona H. 1999. Morphological parameters of blood platelets before and after renal artery embolization in patients with renal cancer. Roczniki Akademii Medycznej W Bialymstoku 44:55-63.
21. McDougal WS, Garnick MB. 1995. Clinical signs and symptoms of renal cell carcinoma. In: Vogelzang NJ, Scardino PT, Shipley WU, Coffey DS, editors. Comprehensive textbook of genitourinary oncology. Baltimore: Williams & Wilkins Co. pp.154-159;111-115.
22. Mullauer L, Gruber P, Sebinger D, Buch J, Wohlfart S, Chott A. 2001. Mutations in apoptosis genes: a pathogenetic factor for human disease. Mutat Res 488:211. (Pubitemid 32521033)
23. Pretorius E, Bornman MS, Marx J, Smit E, van der Merwe CF. 2006. Ultrastructural effects of low dosage endocrine disrupter chemicals on neural cells of the chicken embryo model. Hormone Met Res 38:639-649. (Pubitemid 44759214)
24. Pretorius E, Oberholzer HM, Smit E, Steyn E, Briedenhann S, Franz RC. 2008. Ultrastructural changes in platelet aggregates of HIV patients: A scanning electron microscopical study. Ulstrastructural Pathol 32:75-79. (Pubitemid 351882984)
25. Rosenblum SL. 1987. Paraneoplastic syndromes associated with renal cell carcinoma. J S C Med Assoc 83:375-378.
26. Schafer AI. 2004. Thrombocytosis. N Engl J Med 350:1211-1219.
27. Strewler GJ, Stern PH, Jacobs JW, Eveloff J, Klein RF, Leung SC, Rosenblatt M, Nissenson RA. 1987. Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. J Clin Invest 80:1803-1807. (Pubitemid 18007159)
28. Suva LJ, Winslow GA, Wettenhall RE, Hammonds RG, Moseley JM, Diefenbach-Jagger H, Rodda CP, Kemp BE, Rodriguez H, Chen EY. 1987. A parathyroid hormone-related protein implicated in malignant hypercalcemia: Cloning and expression. Science 237:893-896.
29. Symbas NP, Townsend MF, El-Galley R, Keane TE, Graham SD, Petros JA. 2000. Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma. BJU Int 86:203. (Pubitemid 30621216)
30. Verheul HM, Pinedo HM. 2003. The importance of platelet counts and their contents in cancer. Clin Cancer Res 9:3219.